An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

David A Reardon Center for Neuro-Oncology, Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA, USA. [email protected]; Center for Neuro-Oncology, Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA, USA. [email protected]

Kai W Wucherpfennig Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA, USA; Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA, USA

Gordon Freeman Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA, USA; Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA, USA

Catherine J Wu Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA, USA; Department of Cancer Immunology and AIDS, Dana–Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA, USA

E Antonio Chiocca Department of Neurosurgery, Brigham and Women’s Hospital, Boston, MA, USA; Department of Neurosurgery, Brigham and Women’s Hospital, Boston, MA, USA

Patrick Y Wen Center for Neuro-Oncology, Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA, USA; Division of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA; Center for Neuro-Oncology, Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA, USA; Division of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

William T Curry Jr Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA

Duane A Mitchell Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA; Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA

Peter E Fecci Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA

John H Sampson Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA; Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA

Glenn Dranoff Department of Medical Oncology and Cancer Vaccine Center, Dana–Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA; Department of Medical Oncology and Cancer Vaccine Center, Dana–Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

show all

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

Articles from other publishers (44)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

Citations (49)

Read on this site (5)

Articles from other publishers (44)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date